arrow
B

Ben Sprangers

ziekenhuis oost-limburg
H指数:51
被引数:8,806

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function”

勘误表:关于“确定肾功能减退患者抗肿瘤药物剂量推荐的方法学”

2026-10-140
OAAI
Large-scale AI analysis reveals missed opportunities in albuminuria testing and disease-modifying therapy implementation

大规模AI分析揭示了白蛋白尿检测和疾病修饰疗法实施中错失的机会

2026-04-070
PRE
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup

抗肿瘤疗法引起的肾毒性作用:第34届急性疾病质量倡议工作组共识报告

2025-12-080
OAAI
Management recommendations for kidney transplantation in patients with plasma cell dyscrasia

浆细胞异常增生患者肾移植的管理建议

2025-07-280
PRE
Single-Nucleus RNA-Sequencing Identifies a Differential Profibrotic Response in Parietal Epithelial Cells in Primary Versus Maladaptive Focal Segmental Glomerulosclerosis

单核RNA测序识别原发性与适应性不良型局灶节段性肾小球硬化中壁层上皮细胞的差异促纤维化反应

2025-06-180
OAAI
A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function

一种用于确定肾功能减退患者抗肿瘤药物给药推荐的方法学

2025-04-011
OAAI
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy
2024-09-013
OAAI
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury

F18-FDG PET成像作为免疫检查点抑制剂相关急性肾损伤的诊断工具

2024-08-080
OAAI
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy

一项随机双盲安慰剂对照2期研究的结果表明,iptacopan可作为IgA肾病的替代补体途径抑制剂

2024-01-0134
OAAI
An observational cohort study of histological screening for BK polyomavirus nephropathy following viral replication in plasma

血浆中病毒复制后BK多瘤病毒肾病的组织学筛查的观察性队列研究

2023-11-017
OAAI
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII plus innate immune cells in rejection
2023-07-1940
OAAI